FENTANYL TRANSDERMAL is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Specgx Llc. The primary component is Fentanyl.
| Product ID | 0406-9150_301a8c6d-a664-4eac-9c9e-8c47eb34dae4 |
| NDC | 0406-9150 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FENTANYL TRANSDERMAL |
| Generic Name | Fentanyl Transdermal |
| Dosage Form | Patch, Extended Release |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2020-05-06 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077154 |
| Labeler Name | SpecGx LLC |
| Substance Name | FENTANYL |
| Active Ingredient Strength | 50 ug/h |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-05-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0406-9000 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9012 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9025 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9037 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9050 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9062 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9075 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9100 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9112 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9125 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9150 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 0406-9175 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 63629-4764 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 63629-4771 | FENTANYL TRANSDERMAL | fentanyl transdermal |
| 63629-4773 | FENTANYL TRANSDERMAL | fentanyl transdermal |